CLASS II ONGOING Device recall · Reported 17 Nov 2021 · FDA Enforcement Report

Cellex Photopheresis Procedural Kit Product recalled by Therakos

Therakos is recalling Cellex Photopheresis Procedural Kit, distributed in Illinois. The recall was initiated on 4 Oct 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT # K307 EXPIRATION DATE: 2023-02-01 UDI: (01)20705030200003(10)K307(17)230201
Quantity recalledFive (5) Cases -3 Kits/Case= 15 Kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0212-2022
FDA event ID
88852
Recalling firm
Therakos, West Chester, PA
Classification
Class II
Status
Ongoing
Recall initiated
4 Oct 2021
FDA classified
5 Nov 2021
Reported
17 Nov 2021
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Packaging Defects

Timeline

4 Oct 2021Recall initiated by company
5 Nov 2021Classified by FDA+32 days
17 Nov 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA

Where it was distributed

IL

Illinois

Questions about this recall

Why was it recalled?

Product was released prior to all testing being completed. If used and a drive tube leak were to occur, may cause illness or injury.

Which lots are affected?

LOT # K307 EXPIRATION DATE: 2023-02-01 UDI: (01)20705030200003(10)K307(17)230201

Where was it sold?

IL

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Therakos

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IICellex Photopheresis System is a photoimmune therapy recalledTherakosPackaging DefectsNationwide

Other Other Medical Devices recalls

All 13,778